Importantly, we established mouse model of NAFLD and verified two hub genes NDUFA9 and UQCRQ, which may act as biomarkers and therapeutic targets for NAFLD. Here, NDUFA9 is linked to metabolic dysfunction-associated steatotic liver disease.